When Vessels and Sarcomas Combine: A Review of the Inferior Vena Cava Leiomyosarcoma

Author:

Gama João Martins12ORCID,Almeida Rui1,Oliveira Rui Caetano34567,Casanova José45678

Affiliation:

1. Pathology Department, Centro Hospitalar e Universitário de Coimbra, Hospitais Universitários de Coimbra, 3000-075 Coimbra, Portugal

2. Doctoral Programme in Molecular Pathology and Genetics, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), 4050-313 Porto, Portugal

3. Centro de Diagnóstico Anatomopatológico Germano de Sousa, 3000-377 Coimbra, Portugal

4. Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal

5. Centre of Investigation on Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal

6. Clinical and Academic Center of Coimbra (CACC), 3000-075 Coimbra, Portugal

7. Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal

8. Tumor Unit of the Locomotor Apparatus (UTAL), University Clinic of Orthopedics, Orthopedics Service, Coimbra Hospital and University Centre (CHUC), 3000-075 Coimbra, Portugal

Abstract

Leiomyosarcomas (LMSs) are malignant neoplasms of soft muscle differentiation that can be classified into five distinct groups according to site-related origin: intra-abdominal, subcutaneous or deep soft tissue of the limbs, cutaneous, external genitalia, and vascular. This distinction reflects different biological behaviors as well as molecular changes, thus reflecting different prognoses and therapeutic options. Vascular LMSs are the least frequent, arising from the walls of the blood vessels, most commonly from the inferior vena cava. Due to its deep location, symptoms are non-specific, and the disease presents at an advanced stage, sometimes with metastases. Surgery is the treatment of choice, associated with chemo- and radiotherapy. Due to its rarity, most departments have minimal experience handling this disease. This article reviews the current knowledge on vascular leiomyosarcomas, particularly the inferior vena cava leiomyosarcoma.

Publisher

MDPI AG

Reference92 articles.

1. IARC (2023, August 06). WHO Classification of Soft Tissue and Bone Tumours. WHO Classification of Tumours Soft Tissue and Bone Tumours, Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167394/.

2. Fletcher, C.D.M. (2020). Diagnostic Histopathology of Tumors, Elsevier. [5th ed.].

3. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma;Roland;JAMA Surg.,2016

4. Ein Fall von Sarkom der Vena cava inferior;Perl;Arch Pathol. Anat. Physiol. Klin. Med.,1871

5. Incidence of soft tissue sarcoma and beyond;Mastrangelo;Cancer,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3